Analyst Price Targets — CLPT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 21, 2025 2:15 pm | Frank Takkinen | Lake Street | $30.00 | $15.44 | TheFly | ClearPoint Neuro price target raised to $30 from $17 at Lake Street |
| August 27, 2024 8:45 am | Frank Takkinen | Loop Capital Markets | $15.00 | $12.60 | StreetInsider | Clearpoint Neuro Inc. (CLPT) PT Raised to $15 at Lake Street Capital Markets |
| March 13, 2024 4:35 am | Mathew Blackman | Stifel Nicolaus | $9.00 | $7.17 | StreetInsider | Clearpoint Neuro Inc. (CLPT) PT Raised to $9 at Stifel |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CLPT

ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.2 per share a year ago.

Record Revenue and IRRAS Holdings Acquisition Highlight the Company's 'Fast. Forward.' Strategy SOLANA BEACH, CA / ACCESS Newswire / March 17, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its fourth quarter and full year ended December 31, 2025.

ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2025 fourth quarter and full year on Tuesday, March 17th, after the market close. Investors and analysts are invited to listen to the live…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLPT.
U.S. House Trading
No House trades found for CLPT.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
